vs

Side-by-side financial comparison of CME Group (CME) and Zebra Technologies (ZBRA). Click either name above to swap in a different company.

CME Group is the larger business by last-quarter revenue ($1.9B vs $1.5B, roughly 1.3× Zebra Technologies). Zebra Technologies runs the higher net margin — 4.7% vs 0.1%, a 4.7% gap on every dollar of revenue. On growth, CME Group posted the faster year-over-year revenue change (14.5% vs 10.6%). Over the past eight quarters, Zebra Technologies's revenue compounded faster (12.0% CAGR vs 10.8%).

CME Group Inc. is an American financial services company based in Chicago, Illinois. It operates financial derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX), and the Commodity Exchange (COMEX). The company owns 27% of S&P Dow Jones Indices. It is the world's largest operator of financial derivatives exchanges. Its exchanges are platforms for trading in agricultural products, currencies, energy, i...

Zebra Technologies Corporation (ZBR), commonly known as Zebra, is an American multinational technology conglomerate corporation specializing in smart data capture systems. Zebra is headquartered in Lincolnshire, Illinois outside of Chicago with 10,700 employees across 57 countries.

CME vs ZBRA — Head-to-Head

Bigger by revenue
CME
CME
1.3× larger
CME
$1.9B
$1.5B
ZBRA
Growing faster (revenue YoY)
CME
CME
+3.9% gap
CME
14.5%
10.6%
ZBRA
Higher net margin
ZBRA
ZBRA
4.7% more per $
ZBRA
4.7%
0.1%
CME
Faster 2-yr revenue CAGR
ZBRA
ZBRA
Annualised
ZBRA
12.0%
10.8%
CME

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CME
CME
ZBRA
ZBRA
Revenue
$1.9B
$1.5B
Net Profit
$1.2M
$70.0M
Gross Margin
47.3%
Operating Margin
0.1%
9.4%
Net Margin
0.1%
4.7%
Revenue YoY
14.5%
10.6%
Net Profit YoY
20.7%
-57.1%
EPS (diluted)
$1.40

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CME
CME
ZBRA
ZBRA
Q1 26
$1.9B
Q4 25
$1.6B
$1.5B
Q3 25
$1.5B
$1.3B
Q2 25
$1.7B
$1.3B
Q1 25
$1.6B
$1.3B
Q4 24
$1.5B
$1.3B
Q3 24
$1.6B
$1.3B
Q2 24
$1.5B
$1.2B
Net Profit
CME
CME
ZBRA
ZBRA
Q1 26
$1.2M
Q4 25
$1.2B
$70.0M
Q3 25
$908.0M
$101.0M
Q2 25
$1.0B
$112.0M
Q1 25
$956.2M
$136.0M
Q4 24
$874.6M
$163.0M
Q3 24
$912.8M
$137.0M
Q2 24
$883.2M
$113.0M
Gross Margin
CME
CME
ZBRA
ZBRA
Q1 26
Q4 25
47.3%
Q3 25
48.0%
Q2 25
47.6%
Q1 25
49.3%
Q4 24
48.6%
Q3 24
48.8%
Q2 24
48.4%
Operating Margin
CME
CME
ZBRA
ZBRA
Q1 26
0.1%
Q4 25
61.8%
9.4%
Q3 25
63.3%
13.9%
Q2 25
66.7%
14.2%
Q1 25
67.5%
14.9%
Q4 24
62.1%
16.9%
Q3 24
64.6%
15.2%
Q2 24
65.3%
13.7%
Net Margin
CME
CME
ZBRA
ZBRA
Q1 26
0.1%
Q4 25
71.7%
4.7%
Q3 25
59.1%
7.7%
Q2 25
60.6%
8.7%
Q1 25
58.2%
10.4%
Q4 24
57.3%
12.2%
Q3 24
57.6%
10.9%
Q2 24
57.6%
9.3%
EPS (diluted)
CME
CME
ZBRA
ZBRA
Q1 26
Q4 25
$3.24
$1.40
Q3 25
$2.49
$1.97
Q2 25
$2.81
$2.19
Q1 25
$2.62
$2.62
Q4 24
$2.40
$3.14
Q3 24
$2.50
$2.64
Q2 24
$2.42
$2.17

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CME
CME
ZBRA
ZBRA
Cash + ST InvestmentsLiquidity on hand
$2.4B
$125.0M
Total DebtLower is stronger
$3.4B
Stockholders' EquityBook value
$3.6B
Total Assets
$202.0B
$8.5B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CME
CME
ZBRA
ZBRA
Q1 26
$2.4B
Q4 25
$4.5B
$125.0M
Q3 25
$2.6B
$1.1B
Q2 25
$2.1B
$872.0M
Q1 25
$1.5B
$879.0M
Q4 24
$3.0B
$901.0M
Q3 24
$2.4B
$676.0M
Q2 24
$1.9B
$411.0M
Total Debt
CME
CME
ZBRA
ZBRA
Q1 26
$3.4B
Q4 25
Q3 25
$2.2B
Q2 25
$2.2B
Q1 25
$2.2B
Q4 24
Q3 24
$2.2B
Q2 24
$2.2B
Stockholders' Equity
CME
CME
ZBRA
ZBRA
Q1 26
Q4 25
$28.7B
$3.6B
Q3 25
$28.2B
$3.7B
Q2 25
$27.7B
$3.6B
Q1 25
$27.0B
$3.6B
Q4 24
$26.5B
$3.6B
Q3 24
$28.2B
$3.4B
Q2 24
$27.6B
$3.3B
Total Assets
CME
CME
ZBRA
ZBRA
Q1 26
$202.0B
Q4 25
$198.4B
$8.5B
Q3 25
$187.1B
$8.1B
Q2 25
$179.9B
$7.9B
Q1 25
$157.8B
$7.9B
Q4 24
$137.4B
$8.0B
Q3 24
$137.8B
$7.7B
Q2 24
$123.4B
$7.5B
Debt / Equity
CME
CME
ZBRA
ZBRA
Q1 26
Q4 25
Q3 25
0.58×
Q2 25
0.60×
Q1 25
0.60×
Q4 24
Q3 24
0.64×
Q2 24
0.66×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CME
CME
ZBRA
ZBRA
Operating Cash FlowLast quarter
$357.0M
Free Cash FlowOCF − Capex
$327.0M
FCF MarginFCF / Revenue
22.2%
Capex IntensityCapex / Revenue
2.0%
Cash ConversionOCF / Net Profit
5.10×
TTM Free Cash FlowTrailing 4 quarters
$831.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CME
CME
ZBRA
ZBRA
Q1 26
Q4 25
$1.1B
$357.0M
Q3 25
$968.1M
$235.0M
Q2 25
$1.1B
$147.0M
Q1 25
$1.1B
$178.0M
Q4 24
$1.0B
$306.0M
Q3 24
$1.0B
$294.0M
Q2 24
$776.9M
$288.0M
Free Cash Flow
CME
CME
ZBRA
ZBRA
Q1 26
Q4 25
$1.1B
$327.0M
Q3 25
$949.7M
$216.0M
Q2 25
$1.0B
$130.0M
Q1 25
$1.1B
$158.0M
Q4 24
$991.7M
$288.0M
Q3 24
$973.2M
$277.0M
Q2 24
$758.7M
$278.0M
FCF Margin
CME
CME
ZBRA
ZBRA
Q1 26
Q4 25
66.8%
22.2%
Q3 25
61.8%
16.4%
Q2 25
61.5%
10.1%
Q1 25
67.1%
12.1%
Q4 24
65.0%
21.6%
Q3 24
61.4%
22.1%
Q2 24
49.5%
22.8%
Capex Intensity
CME
CME
ZBRA
ZBRA
Q1 26
Q4 25
2.0%
2.0%
Q3 25
1.2%
1.4%
Q2 25
1.1%
1.3%
Q1 25
0.9%
1.5%
Q4 24
1.7%
1.3%
Q3 24
1.9%
1.4%
Q2 24
1.2%
0.8%
Cash Conversion
CME
CME
ZBRA
ZBRA
Q1 26
Q4 25
0.96×
5.10×
Q3 25
1.07×
2.33×
Q2 25
1.03×
1.31×
Q1 25
1.17×
1.31×
Q4 24
1.16×
1.88×
Q3 24
1.10×
2.15×
Q2 24
0.88×
2.55×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CME
CME

Segment breakdown not available.

ZBRA
ZBRA

Tangible Products$1.2B83%
Service And Software$255.0M17%

Related Comparisons